Reuters logo
BRIEF-Ablynx enters into cancer deal with UK's Spirogen
February 25, 2013 / 6:36 AM / in 5 years

BRIEF-Ablynx enters into cancer deal with UK's Spirogen

BRUSSELS, Feb 25 (Reuters) - Ablynx NV : * Ablynx and Spirogen enter into a research collaboration to evaluate the

potential of novel toxin-nanobody drug conjugates in cancer

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below